Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study

BACKGROUND: Allergic rhinoconjunctivitis (ARC) due to birch pollen is a growing health concern in Europe. Here, we report the efficacy and safety of 300IR birch pollen sublingual solution administered discontinuously for 2 consecutive years to patients with birch-associated allergic rhinoconjunctivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Worm, Margitta, Rak, Sabina, de Blay, Frédéric, Malling, Hans-Jorgen, Melac, Michel, Cadic, Véronique, Zeldin, Robert K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928083/
https://www.ncbi.nlm.nih.gov/pubmed/24517417
http://dx.doi.org/10.1186/2045-7022-4-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928083/
https://www.ncbi.nlm.nih.gov/pubmed/24517417
http://dx.doi.org/10.1186/2045-7022-4-7

Ejemplares similares